Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer
Clinical trial NCT02650817 · COMPLETED
Trial details
- NCT number
- NCT02650817
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-08-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.